The document discusses a new model where patients are partners in clinical trials. It suggests that patients should be able to communicate with peers, investigators, and primary care physicians before, during, and after trials. It also proposes that patients own their individual trial data and that data can be donated or shared in a de-identified manner with researchers while still maintaining patient privacy.